Disease/Infection News

RSS

Mental health burden experienced in Sweden during COVID-19 pandemic

A new study aimed to determine the mental health burden of adults in Sweden through the data collected in the Omtanke2020 Study between 9th June 2020 and 8th June 2021.

14 Dec 2021

Characteristics of SARS-CoV-2 breakthrough infections tracked in large US study

Researchers from Microsoft Corporation, Fred Hutch Cancer Research Center, and the University of Washington recently published a report on the preprint server medRxiv* wherein they studied a de-identified cohort from the United States medical claims records from Change Healthcare to estimate the risk of hospitalization and death, by vaccine type and by previous SARS-CoV2 infection, among SARS-CoV-2 breakthrough infections in fully vaccinated individuals.

14 Dec 2021

SARS-CoV-2 transmission through indoor aerosols

A recent review published in the International Journal of Indoor Environment and Health presents the science behind the person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an indoor environment.

14 Dec 2021

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

A highly anticipated clinical trial in eight sub-Saharan countries is the first to specifically evaluate the efficacy of a COVID-19 vaccine in people living with HIV, including those with poorly controlled infections.

13 Dec 2021

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Researchers from the Duke Molecular Physiology Institute have been investigating genetic associations with more severe disease and examining the associations that certain genetic features have with other diseases.

13 Dec 2021

Omicron variant may strike double vaccinated

Largely, scientists are skeptical that the Omicron variant can infect vaccinated individuals. However, a new study published on the medRxiv* preprint server has conducted neutralization assays using an Omicron isolate obtained from patients residing in the United Kingdom.

13 Dec 2021

Determination of the effectiveness of COVID-19 vaccination using T cell receptor repertoire

A new study published on the bioRxiv preprint server has hypothesized that T cell receptors (TCR) repertoire can measure the response to vaccines, as it would identify the TCR of clones that respond to the vaccination.

13 Dec 2021

Novel breathalyzer relies on viral RNA detection to diagnose SARS-CoV-2

In a new study in The Journal of Molecular Diagnostics, published by Elsevier, investigators report on the design and testing of a breathalyzer, known as the Bubbler, that relies on viral RNA detection to diagnose SARS-CoV-2.

13 Dec 2021

Hotel-based protective housing minimizes COVID-19 rates in vulnerable homeless population

Persons experiencing homelessness (PEH) who were at high risk of severe COVID-19 were 2.5 times less likely to contract SARS-CoV-2 if they were provided with individual hotel rooms and medical and social support compared to citywide rates in homeless shelters, according to new research from the University of Chicago Medicine, Lawndale Christian Health Center, and the Chicago Department of Public Health.

13 Dec 2021

CRISPR-Cas enzyme-based diagnostics to detect SARS-CoV-2 infection

A recent review in the journal Life provided a detailed description of CRISPR-Cas-based diagnostic techniques to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but also emphasized the potential use of this technology towards developing effective molecular diagnostic platforms for any future pandemic.

13 Dec 2021

A model-based evaluation on the effectiveness of social distancing in COVID

Researchers utilize a mathematical model-based analysis to assess how social distancing measures contained the COVID-19 pandemic and reduced mortality.

13 Dec 2021

Characteristics of vaccine breakthroughs in fully vaccinated individuals in France with delta variant

In a recent observational study, scientists have described the characteristics of VBIs in fully vaccinated individuals in France.

13 Dec 2021

New England research on population immunity and SARS-CoV-2

A new study discusses a model-based reconstruction of SARS-CoV-2 attack rate and population-immunity curves for three New England states.

13 Dec 2021

Iota-carrageenan inhibits replication of SARS-CoV-2 VOCs

Scientists have recently reported the efficacy of carrageenan against both the SARS-CoV-2 original strain as well as the Alpha, Beta, Gamma, and Delta VOCs.

13 Dec 2021

Novel assay using finger-prick samples provides COVID-19 vaccine efficacy data

Researchers estimate vaccine efficacy over a period post-vaccination using quantitative antibody assay on finger-prick blood samples.

13 Dec 2021

People with HIV more likely to develop heart failure, study finds

People with HIV are at higher risk of developing heart failure than people without HIV, a new study found.

13 Dec 2021

New technology could help determine COVID-19 patients at risk for micro thrombosis-related issues

Physicians treating coronavirus infections have a new diagnostic that could help identify patients at risk of organ failure.

13 Dec 2021

Glycans strengthen interaction between viral spike proteins and ACE2 receptors on host cells

A new study shows that the ACE2 and RBD of coronavirus spike fragments have different binding strengths and dissociation rates when they are glycosylated and non-glycosylated.

13 Dec 2021

Evaluating the virucidal activity of blue LED light against SARS-CoV-2 infection

A new study provides some possible explanations to the mechanisms by which antiviral activity is exerted by blue LED light and indicated that the alteration of the SARS-CoV-2 spike protein requires the presence of photosensitizers.

13 Dec 2021

Impact of tumor environments on susceptibility and course of disease in those infected with SARS-CoV-2

A review assessed the impact of "hot" vs. "cold" immune/tumor environments (and associated therapies) on susceptibility and disease course in subjects with these two types of tumors and infected with SARS-CoV-2 to decipher the mechanisms that drive these adverse outcomes in COVID-19 infected cancer patients.

13 Dec 2021

Disease/Infection News

Mental health burden experienced in Sweden during COVID-19 pandemic

Characteristics of SARS-CoV-2 breakthrough infections tracked in large US study

SARS-CoV-2 transmission through indoor aerosols

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Omicron variant may strike double vaccinated

Determination of the effectiveness of COVID-19 vaccination using T cell receptor repertoire

Novel breathalyzer relies on viral RNA detection to diagnose SARS-CoV-2

Hotel-based protective housing minimizes COVID-19 rates in vulnerable homeless population

CRISPR-Cas enzyme-based diagnostics to detect SARS-CoV-2 infection

A model-based evaluation on the effectiveness of social distancing in COVID

Characteristics of vaccine breakthroughs in fully vaccinated individuals in France with delta variant

New England research on population immunity and SARS-CoV-2

Iota-carrageenan inhibits replication of SARS-CoV-2 VOCs

Novel assay using finger-prick samples provides COVID-19 vaccine efficacy data

People with HIV more likely to develop heart failure, study finds

New technology could help determine COVID-19 patients at risk for micro thrombosis-related issues

Glycans strengthen interaction between viral spike proteins and ACE2 receptors on host cells

Evaluating the virucidal activity of blue LED light against SARS-CoV-2 infection

Impact of tumor environments on susceptibility and course of disease in those infected with SARS-CoV-2

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News